Magnendo

Funding and NIH signals

• SEC Form D raise Raised $18M (Form D filed Jul 29, 2026). SEC Form D 0002026763-26-000003 (Jul 29, 2026)
  Evidence (1 event)

  • Jul 29, 2026 · SEC Form D 0002026763-26-000003
    Name of Issuer: Magnendo Corp.; CIK: 2026763; Address: Newton, MA; Submission type: D; Filing date: 2026-07-29; Industry Group: Biotechnology; Date of First Sale: 2026-07-17; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 18000000; Total Amount Sold: 18000000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Raises and deals from press releases

• Raise Series A · $18M · announced Jul 24, 2026 Company release ↗
  Source quote

  • Jul 24, 2026 · Company release ↗
    “NEWTON, Mass., July 24, 2026 ( GLOBE NEWSWIRE ) — Magnendo Corp., an MIT spinout developing magnetic robotic navigation technology for neuro-endovascular intervention, today announced the closing of an $18 million Series A financing led by Penumbra”

Raises announced in these releases: $18M disclosed.

From the company’s own releases; this list is partial. All raises and deals